摘要
目的探讨头孢替安联合氨溴索注射液治疗老年社区获得性肺炎(CAP)的临床疗效及安全性。方法选取2015年1月—2016年2月于上海市崇明县三星镇社区卫生服务中心收治的CAP患者70例,按照治疗方法不同将患者分为对照组30例与观察组40例。对照组给予头孢替安治疗,观察组给予头孢替安联合氨溴索治疗。比较两组患者临床疗效,发热、咳痰症状缓解时间、治疗时间及不良反应发生情况。结果观察组临床疗效优于对照组(P<0.05)。观察组患者发热、咳痰症状缓解时间及治疗时间短于对照组(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论头孢替安联合氨溴索注射液治疗CAP的临床疗效确切,可有效缓解患者临床症状,缩短治疗时间,且安全性高。
Objective To investigate the clinical effect and the safety of cefotiam combined with ambroxol in treating elderly patients with community acquired pneumonia（ CAP）. Methods A total of 70 cases of CAP patients were selected from January 2015 to February 2016 in Sanxing Community Health Service Center of Chongming District,which were divided into control group（ n = 30） and observation group（ n = 40） according to different treatments. Control group was given cefotiam,observation group was given cefotiam combined with ambroxol. The clinical effect,relief time of fever,cough symptoms,treatment time and the incidence of adverse reactions were compared between the two groups. Results The clinical effect of observation group was better than control group（ P〈0. 05）. The observation group of relief time of fever,cough symptoms and treatment time were shorter than control group（ P〈0. 05）. There was no significant difference in the incidence of adverse reactions between the two groups（ P〉0. 05）. Conclusion Cefotiam combined with ambroxol have an effectively clinical effect in treating elderly patients with CAP,it can effectively relief the clinical symptoms,shorten treatment time,and with high safety.
出处
《临床合理用药杂志》
2017年第9期8-9,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
社区获得性肺炎
头孢替安
氨溴索
治疗结果
Community acquired pneumonia
Cefotiam
Ambroxol
Treatment outcome
